Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

U.S. farmers struggling with slumping incomes and depressed grain prices have been switching to cheaper generic pesticides ...

The FTSE 100 has pulled back with the government’s policy choices creating some negative sentiment. But this gives us a ...

GSK's phase 3 trial shows Blenrep combined with BorDex improves overall survival in relapsed multiple myeloma.

ACELYRIN, INC. (SLRN – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Emily ...

Feeling stuffy and ready to reach for NyQuil, Benadryl, or Sudafed PE? Not so fast. The Food and Drug Administration (FDA) has proposed ending the use of oral phenylephrine, a common ingredient found ...

Citi analyst David Lebowitz has maintained their bullish stance on CRNX stock, giving a Buy rating yesterday. David Lebowitz’s rating is ...

The company is establishing a North Carolina factory for cold medicine as postpandemic pharma demand has grown more ...

The FDA designated 166 products under its breakthrough devices program in its most recent financial year, reversing the ...

This will clear the memory and remove the unwanted, stored channels. The aerial lead will then need to be put back in again. Repeat manual re-tune. Following either of the two options above ...

We read every day so you don't have to. Sign up for CNN Business' nightly newsletter for the top stories you need to know.

124 Years of the Australian Stock Market A breakdown of the Australian stock market’s historical returns since 1900. Presented in an easy-to-digest visual layout. Updated October 2024.